MSH2 Overexpression Due to an Unclassified Variant in 3’-Untranslated Region in a Patient with Colon Cancer
Background: The loss or low expression of DNA mismatch repair (MMR) genes can result in genomic instability and tumorigenesis. One such gene, MSH2, is mutated or rearranged in Lynch syndrome (LS), which is characterized by a high risk of tumor development, including colorectal cancer. However, many...
Main Authors: | Raffaella Liccardo, Antonio Nolano, Matilde Lambiase, Carlo Della Ragione, Marina De Rosa, Paola Izzo, Francesca Duraturo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/8/6/167 |
Similar Items
-
MiR-137 Targets the 3′ Untranslated Region of <i>MSH2</i>: Potential Implications in Lynch Syndrome-Related Colorectal Cancer
by: Raffaella Liccardo, et al.
Published: (2021-09-01) -
The MSH2 c.793-1G>A variant disrupts normal splicing and is associated with Lynch syndrome
by: Yiming Li, et al.
Published: (2023-07-01) -
Simultaneous Analysis of MLH1, MSH2, MSH6, PMS2 and KRAS in Patients with Gastric and Colon Cancer Using Stochastic Sensors
by: Damaris-Cristina Gheorghe, et al.
Published: (2022-09-01) -
Thyroid cancer in a patient with a germline <it>MSH2 </it>mutation. Case report and review of the Lynch syndrome expanding tumour spectrum
by: Stulp Rein P, et al.
Published: (2008-02-01) -
Lynch Syndrome Germline Mutations in Breast Cancer: Next Generation Sequencing Case-Control Study of 1,263 Participants
by: Aleksey G. Nikitin, et al.
Published: (2020-05-01)